REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan Facility and Holding in Company

25 Jan 2024 07:00

RNS Number : 8369A
Location Sciences Group PLC
25 January 2024
 

25 January 2024

 

This announcement contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

Location Sciences Group PLC

("Location Sciences" or the "Company" or the "Group")

 

Term loan facility entered into with Bidco 3 Limited

and

Holding in Company

 

Location Sciences (AIM: LSAI) announces that the Company has entered into an unsecured term loan facility agreement with Bidco 3 Limited (the "Lender" or "Bidco 3") for a total principal amount of up to £3.0 million (the "Facility"). Bidco 3 is a special purpose holding company focused on making appropriate strategic investments.

 

Background to and reasons for the Facility

 

As most recently announced by the Company on 20 December 2023, a considerable amount of work has been carried out in relation to the Company's proposed acquisition of the entire issued share capital of Sorted Holdings Limited ("Sorted") (the "Proposed Acquisition"). As the Company continues to work towards the finalisation of the Proposed Acquisition, the Company is cognisant of its existing overheads and working capital requirements, and those of the Company following completion of the Proposed Acquisition. In this respect, the Facility, subject to the satisfaction of certain customary conditions precedent, will be available for drawdown to be used for, inter alia, providing the Company with general working capital.

 

Key terms and conditions of the Facility

 

The Company may utilise the Facility in one or more tranches, provided that any utilisation of the Facility is for a minimum amount of £0.5 million, with the aggregate amount of funds drawn pursuant to the Facility not exceeding £3.0 million.

 

Borrowings under the Facility will accrue interest daily at 1.5 per cent. per month and shall be repayable on 31 January 2026. The Facility is subject to customary events of default and an arrangement fee of £125,000 is payable to the Lender, which can be satisfied in cash or by the issuance of ordinary shares in the Company at the Lender's option.

 

Holding in Company

 

Separate to the above, Location Sciences was informed on 24 January 2024 that Daron Lee now holds 75,000,000 ordinary shares in the Company, representing approximately 2.83 per cent of the issued share capital of the Company.

 

For further information please contact:

 

Location Sciences Group PLC via Allenby Capital

Simon Wilkinson, Chairman

 

Allenby Capital Limited (Nominated Adviser) Tel: +44 (0)20 3328 5656

David Hart

Vivek Bhardwaj

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSEUEELELSEEF
Date   Source Headline
11th May 20219:05 amRNSSecond Price Monitoring Extn
11th May 20219:00 amRNSPrice Monitoring Extension
6th May 20217:00 amRNSResult of Broker Option
5th May 20212:06 pmRNSSecond Price Monitoring Extn
5th May 20212:00 pmRNSPrice Monitoring Extension
4th May 202111:05 amRNSSecond Price Monitoring Extn
4th May 202111:00 amRNSPrice Monitoring Extension
4th May 20219:05 amRNSSecond Price Monitoring Extn
4th May 20219:00 amRNSPrice Monitoring Extension
4th May 20217:00 amRNSProposed Fundraise of up to £3.85m - Notice of GM
23rd Apr 20212:05 pmRNSSecond Price Monitoring Extn
23rd Apr 20212:00 pmRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSFinal Results for the year ended 31 December 2020
15th Mar 20214:41 pmRNSSecond Price Monitoring Extn
15th Mar 20214:35 pmRNSPrice Monitoring Extension
23rd Feb 202111:00 amRNSPrice Monitoring Extension
19th Feb 20213:36 pmRNSTR-1 Notification of major holdings
11th Feb 202111:06 amRNSSecond Price Monitoring Extn
11th Feb 202111:00 amRNSPrice Monitoring Extension
11th Feb 20219:05 amRNSSecond Price Monitoring Extn
11th Feb 20219:00 amRNSPrice Monitoring Extension
11th Feb 20217:00 amRNSTrading Update and Directorate Changes
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:36 pmRNSPrice Monitoring Extension
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:36 pmRNSPrice Monitoring Extension
21st Jan 20214:41 pmRNSSecond Price Monitoring Extn
21st Jan 20214:36 pmRNSPrice Monitoring Extension
20th Jan 20214:40 pmRNSSecond Price Monitoring Extn
20th Jan 20214:35 pmRNSPrice Monitoring Extension
18th Dec 20207:00 amRNSHolding(s) in Company
17th Dec 20204:41 pmRNSSecond Price Monitoring Extn
17th Dec 20204:35 pmRNSPrice Monitoring Extension
16th Dec 20204:41 pmRNSSecond Price Monitoring Extn
16th Dec 20204:36 pmRNSPrice Monitoring Extension
14th Dec 20207:00 amRNSPotential Defamation Action Against the Company
30th Nov 20207:00 amRNSNew Contract Win and Trading Update
5th Nov 20203:44 pmRNSHolding(s) in Company
30th Oct 20207:00 amRNSIssue of shares to directors in lieu of fees & TVR
1st Oct 20207:00 amRNSAppointment of Nominated Adviser
17th Sep 202012:43 pmRNSHalf-year Report - Replacement
15th Sep 20207:00 amRNSHalf-year Report
1st Sep 20209:05 amRNSSecond Price Monitoring Extn
1st Sep 20209:00 amRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSContract
27th Jul 20207:00 amRNSTrading Update
3rd Jul 202011:05 amRNSSecond Price Monitoring Extn
3rd Jul 202011:00 amRNSPrice Monitoring Extension
1st Jul 202010:02 amRNSIssue of Equity and Total Voting Rights
16th Jun 202010:36 amRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.